Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies

por Yao, Betty B., Fredrick, Linda M., Schnell, Gretja, Kowdley, Kris V., Kwo, Paul Y., Poordad, Fred, Nguyen, Kinh, Lee, Samuel S., George, Christophe, Wong, Florence, Gane, Edward, Abergel, Armand, Spearman, Catherine W., Nguyen, Tuan, Hung Le, Manh, Pham, Thuy TT., Mensa, Federico, Asselah, Tarik
Publicado 2020

Establishing baseline framework for hepatitis B virus micro-elimination in Ho Chi Minh City, Vietnam – A community-based seroprevalence study

por Pham, Trang N.D., Le, Duc H., Dao, Diem V.B., Phan, Loc T.B., Pham, Thuy T.T., Nguyen, Toan B., Mize, Gary W., Gish, Robert G., Lee, William M., Trang, Amy, Le, Anh N., Chen, Moon, Phan, Hai T., Nguyen, Binh T., Tang, Hong K., Dao, Doan Y.
Publicado 2022